Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 10, 2026

Back to today

From X

@junkbondinvest

junkbondinvestor on X

Semafor out with a hitpiece on private credit. They lump the loans together without explaining one is senior and one is junior (both are first lien). But that's beyond the point. $FSK has a 1L loan to a distressed company marked at 98 cents (for reference, TCPC has it at 86 cents). Whatever, fine. And on the same company's JUNIOR tranche 1L debt? They have it marked at 10 cents. Both loans are PIK, already restructured once, and the equity is marked at ZERO. How do you justify a 98 cent mark on a company likely headed for bankruptcy, while simultaneously marking your junior debt at 10 cents? C'mon! Imagine this in public credit markets? This is the kind of shenanigans which makes no one trust PC marks.
@StableBread

Fajasy on X

At ~$6.8M net of cash, Nubeva Technologies $NBVAF (TSXV: $NBVA) trades below every one of the five small ransomware-security deals I found with a disclosed price. That’s a CAD$13.0M market cap at CAD$0.185/share (70,173,783 × CAD$0.185), or $9.3M at 1.40 USD/CAD, with the $2.49M of cash and $12,262 of debt netted out. The $6.8M buys two granted patents, two pending applications, the unfinished AI decryptor builder, and a deployment agreement with what Nubeva calls a top-10 global bank, on $500,586 of FY2026 revenue. Here’s what larger security firms paid for five small companies that detect, stop, or recover from ransomware, per the buyers’ filings: → Smokescreen (June 2021): Zscaler $ZS paid ~$11.7M in cash for a startup that plants decoys to catch attackers. → TrapX Security (January 2022): Commvault $CVLT paid $18.65M in cash for an Israeli decoy-technology company. → Minerva Labs (March 2023): Rapid7 $RPD paid $34.6M for a 14-person Israeli startup selling anti-evasion and ransomware-prevention software. → Appranix (April 2024): Commvault paid $26.27M in cash and stock for a Boston startup that cuts the time to rebuild cloud applications after an attack. → Airgap Networks (April 2024): Zscaler paid $124.4M for an “early-stage” network-security company whose product it called a “ransomware kill switch.” For context, Commvault bought TrapX and Appranix as product lines already bringing in ~$3.2M and ~$2.4M a year. Rapid7 and Zscaler bought Minerva Labs and Airgap mainly for their technology. A buyer would be paying for Nubeva’s technology too, meaning four AI patents (assuming the last two come through), the key-capture agent, and a top-10 bank as a reference account (if the license customer renewed), not just ~$500K of revenue. Still, Nubeva’s revenue is a fifth or less of what TrapX and Appranix brought in, and 82% of its revenue comes from two customers, one of which may not have renewed. So I’d put a sale at the low end of these deals, $12-19M (Smokescreen to TrapX), or CAD$0.23-0.37/share, 1.3-2.0x from here. The ~$26M median (2.8x) is the more bullish upside case. If nothing works, two more years of burn leave $0.93-1.29M of cash, and adding the two granted patents and what’s left of the business gets shareholders $1.33-2.01M, or CAD$0.03-0.04/share, a 78-86% loss from CAD$0.185. In other words, CAD$0.185 sits ~45% of the way between the CAD$0.03-0.04 floor and a TrapX-size sale (CAD$0.37/share). If those are the only two outcomes, the market is pricing a sale as close to a coin flip.
@stockgutter

SG on X

$WQEY $SAIQ $LAES $GIW agree to a Rube Goldberg de-SPAC transaction. According to the headline, the purpose is to have Quantismo "become a Nasdaq-listed public company." But, facts. Quantismo is already owned by two public companies, SealsQ and WiseQey. They could simply spin it out to shareholders. As far as I can tell, Quantismo has no meaningful revenue or operations of its own and is simply a holdco for unserious investments in the sector, including (as part of this transaction) a healthy dollop of shitco WiseSat .space (SAIQ). This isn't a private to public transaction. It's a shell game between four existing pubcos. I suspect that retail investors are the marks.
@convequity

Convequity on X

We prefer $UMC to $GFS, and we are increasing our UMC position. Both companies are foundries that make chips on mature processes, well behind the leading edge. We hold GlobalFoundries as a recovery investment. United Microelectronics offers two things on top of a recovery: a manufacturing partnership with production targeted for 2027, and a longer-term way to make its existing processes more competitive. 1. The nearer-term driver is the 12nm process UMC is developing with $INTC. 12nm is a mature process generation, not a leading-edge one. Production is targeted for 2027 at Intel's factories in Arizona. UMC contributes its foundry experience and its experience working with chip designers. Intel contributes the manufacturing capacity. UMC gains a way to offer customers chips made in the United States without building an American factory itself. UMC could also earn income from intellectual property and revenue sharing, but the commercial terms are not yet clear, so we do not yet count on royalty income. The attraction today is the chance to win customers and expand the business through the partnership. 2. The longer-term driver is logic folding. In a conventional chip, the circuits sit on one layer and signals cross it along long horizontal wires. Folding arranges the circuits across two or more layers connected vertically, so many long horizontal wires become short vertical ones. Signals travel a shorter distance, which takes less time and less energy. The chip gets faster and more energy-efficient without smaller transistors. For UMC, folding could make chips built on its established processes more capable and easier to sell, which extends the value of its factories without matching the most advanced processes at $TSM. We described the mechanism in our Huawei series on the Kirin 9050. 3. We think a mature process is the more manageable place to start folding. Whoever folds chips has to solve bonding, heat removal and reliable high-volume production. UMC would solve those on a transistor process it already understands. Applying folding to TSMC's newest processes would combine two difficult manufacturing changes at once: a new generation of smaller, more complex transistors, and active circuits connected across several layers. A problem with either one can reduce the share of usable chips, raise costs or delay customer launches. This is a difference in the risks being combined. TSMC already offers advanced stacking technologies and has the expertise. 4. The commercial incentives differ as well. For UMC, folding extends the useful life of processes it already owns and lets it compete for business that would otherwise need a newer process. For TSMC, folding on older processes competes with the returns it expects from its leading-edge investments and could disrupt customer roadmaps built around those investments. So UMC has the stronger reason to become an advocate for folding on older processes. This is our prospective thesis about where folding is most likely to be adopted. UMC has not announced a logic-folding program. We have two reservations. UMC's shares have already recovered from their low, so the entry point is less attractive than it was. Logic folding could take years to contribute to revenue. The Intel partnership is our reason to add now. The chance to make UMC's existing processes more competitive is why we hold a larger position in UMC than in GlobalFoundries.

Investor Letters

All letters

TSOH Weekly Roundup (10/09/2026)

Paramount Skydance’s debt-heavy Warner Bros. Discovery acquisition, streaming bundle pricing and alcohol-industry diversification anchor…

WBD $78B
TSOH Investment Research

Boyz in the Hood

Robinhood’s AI agents, 24/7 equity trading and 10:1 crypto perpetual futures encourage higher retail trading velocity, leverage and…

HOOD $98B
WHAT ARE WE DOING? “Contrarians At The Gate”
BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

BNTC $314M
Value Investors Club

Golar LNG q2’26 Operational Update

Golar LNG ordered a $2.45 billion fourth FLNG vessel, targeting 3.5MTPA of capacity and $400 million in annual EBITDA under a 20-year…

GLNG $4.9B
Monte Independent Investment Research

Vertiv Holdings Co. (VRT)

Vertiv's 33% stock decline followed a 2026 forecast increase, despite a $15 billion backlog and rising AI data-center demand for power and…

VRT $94B
SixSigmaCapital: Navigating the Financial Markets

What I’ve Been Up To

Cogent Communications and AI data-center bottlenecks feature in a newsletter update on recruiting, financial media and conference takeaways.

CCOI $515M
Stock Thoughts 1 click

Publications we follow

Every publication on this site, hand-picked.

109 publications

Newsletters 92

YouTube 4

Blogs 12

Seeking Alpha 45 of 216

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

74 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.